J&J to discontinue HIV vaccine trial | Reuters
Johnson & Johnson said on Wednesday the company and its partners will discontinue the late-stage trial of an HIV vaccine after it was found ineffective at preventing infections.
Hier ein lesenswerter Hintergrundartikel aus dem Dt. Ärzteblatt.